{"id":2511,"date":"2024-09-21T11:33:15","date_gmt":"2024-09-21T14:33:15","guid":{"rendered":"https:\/\/clientes.somatecnologia.com\/orygen\/who-we-are\/"},"modified":"2024-11-18T15:03:12","modified_gmt":"2024-11-18T18:03:12","slug":"who-we-are","status":"publish","type":"page","link":"https:\/\/orygen.com.br\/en\/who-we-are\/","title":{"rendered":"who we are"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Orygen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Orygen is a research and development biotechnology company currently focused on products based on Hiltonol\u00ae for human and veterinary use.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Since its creation in 2012, the work at Orygen has been the result of the combined efforts of the company\u00b4s experienced professionals together with the support of two of Brazil\u00b4s principal pharmaceutical companies: Biolab and Eurofarma. Beyond being shareholders, both companies participate in the management and the development of each project. In this way, while operating independently, we have the cutting-edge expertise of the two companies for patenting, regulatory affairs and manufacturing.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

From Brazil to the world<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

We have the capacity to export to 22 countries in Latin America.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

+<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Leadership<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Knowledge makes the difference<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our company is led by professionals who maintain our standards of excellence, facilitate strong interactions with Brazil\u00b4s academic community. Learn a little more about each professional.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

Dr. Andrew Simpson<\/h3>

Scientific Director<\/strong>
One of Brazil\u00b4s most important scientists, with more than four decades of leadership of large-scale projects, combined with more than 20 years of scientific administration at the international level. Responsible for the management of the \u201cProjeto Genoma\u201d in Brazil between the years1995 and 2003, and working at the Ludwig Institute for Cancer Research\u00b4s international head office in New York in various positions, including Global Scientific Director, until returning to Brazil at Orygen\u00b4s invitation, to lead its activities in 2012. <\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

Dra. Otavia Caballero<\/h3>

Research and Development Manager<\/strong>
More than 15 years of experience in scientific research, worked at Ludwig Cancer Research between 2004 and 2014, in the United States. Manages research and development for the company.<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

Luis Augusto Monteiro<\/h3>

Financial Planning Director<\/strong>

More than 40 years\u2019 experience in financial and economic management in large companies and the preparation of economic viability studies with financial institutions and BNDES.<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Mission, Vision and Values<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Mission<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our commitment is the result of the close collaboration with our shareholders, allowing us to optimize our resources and knowledge to significantly boost our potential and impact.<\/span><\/p>\n

At Orygen we believe collaboration, innovation and dedication are the pillars that propel our progress. We are committed to continue leading the way forward in the search of solutions that improve health and global well-being.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vision<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

To be a national and international reference in the production of biopharmaceuticals of technological and scientific excellence, contributing to the development and economic growth of Brazil as well as the improvement of the quality of life of patients.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Values<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
    \n
  • Advancement of innovation<\/li>\n
  • Improved access to treatments<\/li>\n
  • Transparency<\/li>\n
  • Excellence in the development, production and commercialization of biological medicines<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
      \n
    • Continuous staff development<\/li>\n
    • Social and environmental responsibility<\/li>\n
    • Ethics<\/span><\/li>\n
    • Promotion of technological and economic progress<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      Orygen Orygen is a research and development biotechnology company currently focused on products based on Hiltonol\u00ae for human and veterinary use. Since its creation in 2012, the work at Orygen has been the result of the combined efforts of the company\u00b4s experienced professionals together with the support of two of Brazil\u00b4s principal pharmaceutical companies: Biolab […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_theme","meta":{"footnotes":""},"class_list":["post-2511","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/pages\/2511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/comments?post=2511"}],"version-history":[{"count":20,"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/pages\/2511\/revisions"}],"predecessor-version":[{"id":2765,"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/pages\/2511\/revisions\/2765"}],"wp:attachment":[{"href":"https:\/\/orygen.com.br\/en\/wp-json\/wp\/v2\/media?parent=2511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}